New Pharma CEE - Company finances
- The company is late in submitting financial data for the previous financial year.
- The company has not submitted financial data for these years: 2023, 2024.
- Latest financial data up to 2022-12-31.
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 204,115 | 154,187 | 119,400 | 176,029 | 243,750 |
| Profit before tax | 138,728 | 124,078 | -9,080 | 162,235 | 99,165 |
| Net profit | 132,378 | 119,771 | -9,080 | 161,894 | 98,182 |
| Equity | 1,630,426 | 1,650,198 | 1,491,118 | 1,503,012 | 1,276,194 |
| Liabilities | 676,671 | 1,241,109 | 2,166,650 | 2,492,740 | 2,493,912 |
| Non-current assets | 320,554 | 320,266 | 319,925 | 319,783 | 286,128 |
| Current assets | 1,987,418 | 2,571,018 | 3,337,608 | 3,678,562 | 3,485,816 |
| Total assets | 2,307,972 | 2,891,284 | 3,657,533 | 3,998,345 | 3,771,944 |
|
Taxes paid
|
|||||
| STI taxes | - | - | - | - | - |
| Social insurance contributions | - | - | - | - | - |
|
Financial indicators
|
|||||
| Revenue change y/y | - | -24.5% | -22.6% | +47.4% | +38.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 5.7% | 4.1% | -0.2% | 4.0% | 2.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 8.1% | 7.3% | -0.6% | 10.8% | 7.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 64.9% | 77.7% | -7.6% | 92.0% | 40.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 68.0% | 80.5% | -7.6% | 92.2% | 40.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 0.8 | 1.5 | 1.7 | 2.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 68,038 | 68,528 | 37,705 | 41,419 | 121,875 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
New Pharma CEE - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-05-28 | 0.06 |
| 2026-04-24 | 2026-04-29 | 0.06 |
| 2026-03-29 | 2026-03-30 | 16.08 |
| 2026-03-17 | 2026-03-27 | 16.08 |
| 2025-12-16 | 2025-12-30 | 1.95 |
| 2025-09-16 | 2025-09-25 | 4.97 |
| 2025-08-19 | 2025-08-29 | 1.94 |
| 2025-07-24 | 2025-07-30 | 1.94 |
| 2025-05-16 | 2025-05-18 | 920.58 |
| 2025-04-16 | 2025-04-21 | 883.19 |
| 2023-11-16 | 2023-11-29 | 0.15 |
| 2023-10-25 | 2023-11-14 | 0.15 |
New Pharma CEE - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-21 | 2026-02-21 | 57.92 |
| 2025-06-14 | 2025-06-16 | 455.95 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.